New York State Common Retirement Fund Exagen Inc. Transaction History

New York State Common Retirement Fund

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$4.18 - $7.74 $28,423 - $52,632	-6,800 Reduced 98.59%	97 $1,000
Q4 2021 Feb 02, 2022	SELL	$8.97 - $14.08 $233 - $366	-26 Reduced 0.38%	6,897 $80,000
Q3 2021 Nov 02, 2021	SELL	$10.25 - $15.21 $41,164 - $61,083	-4,016 Reduced 36.71%	6,923 $94,000
Q2 2021 Aug 02, 2021	BUY	$12.4 - $17.92 $78,603 - $113,594	6,339 Added 137.8%	10,939 $164,000
Q4 2019 Feb 05, 2020	BUY	$12.61 - $28.48 $58,006 - $131,008	4,600 New	4,600 $117,000

6.41M

4.5K

400

Ticker XGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 16,260,400
Market Cap $89.8M
Description
Exagen Inc. develops and commercializes various testing products based on its cell-bound complement activation products technology under the AVISE brand in the United States. It enables rheumatologists to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus ery...

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on New York State Common Retirement Fund with notifications on news.